Rock Springs Capital Management LP Kymera Therapeutics, Inc. Transaction History

Rock Springs Capital Management LP

  • $2.94 Billion
  • Q3 2024

A detailed history of Rock Springs Capital Management LP transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 1,049,386 shares of KYMR stock, worth $44.4 Million. This represents 1.69% of its overall portfolio holdings.

Number of Shares
1,049,386
Previous 1,163,973 9.84%
Holding current value
$44.4 Million
Previous $34.7 Million 42.95%
% of portfolio
1.69%
Previous 1.08%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$30.16 - $52.4 $3.46 Million - $6 Million
-114,587 Reduced 9.84%
1,049,386 $49.7 Million
Q2 2024

Aug 14, 2024
SELL
$29.85 - $39.42 $10.7 Million - $14.1 Million
-358,265 Reduced 23.54%
1,163,973 $34.7 Million
Q4 2023

Feb 14, 2024
BUY
$10.97 - $26.84 $196,220 - $480,087
17,887 Added 1.19%
1,522,238 $38.8 Million
Q3 2023

Nov 14, 2023
BUY
$13.9 - $23.88 $233,520 - $401,184
16,800 Added 1.13%
1,504,351 $20.9 Million
Q2 2023

Aug 14, 2023
BUY
$22.4 - $34.92 $5.81 Million - $9.05 Million
259,172 Added 21.1%
1,487,551 $34.2 Million
Q1 2023

May 15, 2023
BUY
$24.84 - $38.75 $14,904 - $23,250
600 Added 0.05%
1,228,379 $36.4 Million
Q4 2022

Feb 14, 2023
BUY
$19.57 - $30.92 $3.54 Million - $5.6 Million
181,036 Added 17.3%
1,227,779 $30.6 Million
Q3 2022

Nov 14, 2022
BUY
$20.91 - $34.27 $5.66 Million - $9.28 Million
270,864 Added 34.91%
1,046,743 $22.8 Million
Q2 2022

Aug 15, 2022
BUY
$14.13 - $42.55 $282,656 - $851,170
20,004 Added 2.65%
775,879 $15.3 Million
Q1 2022

May 16, 2022
BUY
$35.3 - $64.68 $487,492 - $893,230
13,810 Added 1.86%
755,875 $32 Million
Q4 2021

Feb 14, 2022
BUY
$49.91 - $65.56 $456,077 - $599,087
9,138 Added 1.25%
742,065 $47.1 Million
Q3 2021

Nov 15, 2021
BUY
$47.8 - $66.66 $5.09 Million - $7.09 Million
106,400 Added 16.98%
732,927 $43.1 Million
Q2 2021

Aug 16, 2021
BUY
$31.08 - $51.95 $147,630 - $246,762
4,750 Added 0.76%
626,527 $30.4 Million
Q1 2021

May 17, 2021
SELL
$35.64 - $85.46 $3.28 Million - $7.87 Million
-92,088 Reduced 12.9%
621,777 $24.2 Million
Q4 2020

Feb 16, 2021
BUY
$28.07 - $87.83 $109,473 - $342,537
3,900 Added 0.55%
713,865 $44.3 Million
Q3 2020

Nov 16, 2020
BUY
$26.1 - $33.28 $18.5 Million - $23.6 Million
709,965 New
709,965 $22.9 Million

Others Institutions Holding KYMR

# of Institutions
184
Shares Held
64.4M
Call Options Held
50.6K
Put Options Held
81.7K
View Full List

About Kymera Therapeutics, Inc.

KYMR Quotes by TradingView
  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.31B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email